Mesoblast (MESO) Cash from Investing Activities Growth (1y) (2017 - 2023)
Mesoblast (MESO) Cash from Investing Activities Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 134.04% |
| Mar 31, 2023 | 148.21% |
| Dec 31, 2022 | -13.33% |
| Sep 30, 2022 | -105.05% |
| Jun 30, 2022 | 78.92% |
| Mar 31, 2022 | 94.02% |
| Dec 31, 2021 | 92.63% |
| Sep 30, 2021 | -22.22% |
| Jun 30, 2021 | 88.06% |
| Mar 31, 2021 | -35.06% |
| Dec 31, 2020 | 11.33% |
| Sep 30, 2020 | 67.98% |
| Jun 30, 2020 | -134.09% |
| Mar 31, 2020 | -670.00% |
| Dec 31, 2019 | -528.77% |
| Sep 30, 2019 | -548.72% |
| Jun 30, 2019 | -83.03% |
| Mar 31, 2019 | -143.24% |
| Dec 31, 2018 | -35.19% |
| Sep 30, 2018 | 93.77% |